Barely Significant
← all excerpts

Systemic Chemotherapy in Advanced Pancreatic Cancer.

Gut Liver · 2016 · PMC4849685 · PMID 27114434

Europe PMCDOI
1
hedged sentence
0.0800
closest p · 1.6× alpha
0.0800
boldest claim

The sentences

did not reach statistical significancep=0.08so close (0.05 < p ≤ 0.1)
showed a trendp=0.08so close (0.05 < p ≤ 0.1)
The second trial also showed a trend towards an improvement in OS, even if it did not reach statistical significance (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.72 to 1.02; p=0.08). 15 Moreover, a meta-analysis of the two phase III trials showed a significant survival benefit in favor of gemcitabine plus capecitabine (HR, 0.86; 95% CI, 0.75 to 0.98; p=0.02).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.